Golden
Kheiron Medical Technologies

Kheiron Medical Technologies

Biomedical Artificial Intelligence company helping doctors find breast cancer early and more accurately using deep learning.

Kheiron combines deep learning with radiology to find malignancies in mammograms.

Kheiron has a breast screening product called Mia which won an award for Best New Radiology Software in the 2019 EuroMinnies. The company also received CE marking for its breast cancer screening machine learning software, allowing it to be used within the UK National Health Service (NHS) and European healthcare systems.

Kheiron’s software is used as a second reader of mammographic images and clinicians receive results within seconds. The product could reduce the screening workload on clinical staff. Depending on the algorithm’s findings certain studies can be prioritised. The product aims to make breast cancer detection more efficient and more accurate as detecting cancer at an earlier stage.

An independent multi-center clinical study evaluated the performance of their software and found that it surpassed recognized standards for accuracy with single radiologist reporting.

Timeline

September 2019

Kheiron Medical Technologies raises a $22,000,000 series A round from Connect Ventures, Exor, Atomico, Greycroft and Hoxton Ventures.

2016

Kheiron Medical Technologies was founded by Peter Kecskemethy and Tobias Rijken.

Funding rounds

Funding round
Description
Funding round amount (USD)
Funding type
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

David Pribil

Employee

Joe Yearsley

Employee

Peter Kecskemethy

Founder

Tobias Rijken

Founder

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References